60 Degrees Pharmaceuticals, Inc.
SXTP· Nasdaq
Released Nov 16, 2026, during market hours
10-Q filed Nov 16, 2026, 47 days after period end · 0001554855-26-002390
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $233.24K | $437.60K | $135.29K | $51.19K |
| Net Income | -$2.56M | -$2.32M | -$2.16M | $4.18M |
| EPS Diluted | -$0.75 |
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
| -$2.66 |
| -$2.92 |
| $9.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.